Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel after PCI in STEMI
IRCT20180205038626N9Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in myocardial infarction (MI) comparing Clopidogrel + aspirin with Ticagrelor + aspirin (2 arms). Primary endpoints: Death, Myocardial infarction and 2 more. Started Aug 2021; status: completed.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20180205038626N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180205038626N9.